Cargando…

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance

BACKGROUND: Tuberculosis (TB) is the world’s leading infectious cause of death. Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over half a million people were newly diagnosed with rifampicin‐resistant TB in 2016. Xpert(®) MTB/RIF (Xpert) is a World Health Organ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kohli, Mikashmi, Schiller, Ian, Dendukuri, Nandini, Dheda, Keertan, Denkinger, Claudia M, Schumacher, Samuel G, Steingart, Karen R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2018
Materias:	Medicine General & Introductory Medical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513199/ https://www.ncbi.nlm.nih.gov/pubmed/30148542 http://dx.doi.org/10.1002/14651858.CD012768.pub2

Ejemplares similares

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms
por: Shapiro, Adrienne E, et al.
Publicado: (2021)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2022)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
por: Shah, Maunank, et al.
Publicado: (2016)

Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis
por: Sharma, Surendra K, et al.
Publicado: (2015)

Evaluation of Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis in Southwest China
por: Li, Tong-xin, et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

Scaling-up the Xpert MTB/RIF assay for the detection of tuberculosis and rifampicin resistance in India: An economic analysis
por: Khaparde, Sunil, et al.
Publicado: (2017)

Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance
por: Allahyartorkaman, Mohammadreza, et al.
Publicado: (2019)

Xpert(®) MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis
por: Njau, Allan N., et al.
Publicado: (2019)

The use of Gene-Xpert MTB RIF in the diagnosis of extrapulmonary tuberculosis in childhood and adolescence
por: Aurilio, Rafaela Baroni, et al.
Publicado: (2020)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
por: Cayci, Yeliz Tanriverdi, et al.
Publicado: (2017)

Xpert MTB/RIF assay for diagnosis of extrapulmonary tuberculosis in children: a systematic review and meta-analysis
por: Seo, Young Seok, et al.
Publicado: (2020)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
por: Mukhida, Sahjid, et al.
Publicado: (2022)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
por: Zong, Kaican, et al.
Publicado: (2019)

Difficulties with the implemented xpert MTB/RIF for determining diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children
por: Mertaniasih, Ni Made, et al.
Publicado: (2020)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
por: De Vos, Elise, et al.
Publicado: (2023)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
por: Wu, Zheyuan, et al.
Publicado: (2020)

Detection of Mycobacterium tuberculosis and Rifampicin Resistance Using GeneXpert MTB/RIF Assay at Enat Hospital, Central Ethiopia
por: Selfegna, Sebsib, et al.
Publicado: (2022)

Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis
por: Patel, Sakshi, et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF Ultra for the Diagnosis of Extrapulmonary Tuberculosis: A Retrospective Analysis in Saudi Arabia
por: Slail, Mousa J., et al.
Publicado: (2023)

Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden
por: van Zyl-Smit, Richard N., et al.
Publicado: (2011)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
por: Dorman, Susan E, et al.
Publicado: (2018)

Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study
por: Rachow, Andrea, et al.
Publicado: (2011)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2013)

Tissue Xpert® MTB/RIF Assay in Peritoneal Tuberculosis: To be (Done) or Not to be (Done)
por: Dahale, Amol S, et al.
Publicado: (2019)

Comparative Performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for Early Diagnosis of Rifampicin-Resistant Pulmonary Tuberculosis
por: Yadav, Raj Narayan, et al.
Publicado: (2021)

Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests
por: MacLean, Emily L., et al.
Publicado: (2022)

Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review
por: Maynard-Smith, Laura, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ujm9uk6bcc3skvcsgqdslfhett